AIM2 and colorectal carcinoma: Considering that AIM2 only exhibit effects in BRAF-mutant CRC cells, these data suggested that the DNA-PK/Akt pathway or PTEN was not involved in the AIM2-induced necrotic-like cell death in BRAF-mutant CRC (Figure 3B).